Multiple myeloma diagnosis and treatment markers and their application
A multiple myeloma, material technology, applied in the field of tumor diagnosis, prognosis prediction, treatment, can solve problems such as inevitable recurrence
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0074] Example 1 Gene Chip Screening for Differentially Expressed Genes
[0075] 1. Materials:
[0076] Multiple myeloma tissue: A total of 10 bone marrow biopsy specimens were collected from confirmed MM patients. The diagnostic criteria for MM refer to the "Chinese Guidelines for the Diagnosis and Treatment of Multiple Myeloma 2011 Revised Edition". Among the patients, there were 5 males and 5 females, with a median age of 59 years.
[0077] Normal bone marrow tissue: 10 bone marrow biopsy specimens were collected from patients with malnutrition anemia at the same period as the control group, including 5 males and 5 females, with a median age of 53 years.
[0078] 2. Obtaining tissue RNA
[0079] Total tissue RNA was extracted using the Trizol one-step method.
[0080] 3. Determination of RNA purity and concentration
[0081] Take 1 μl of RNA solution, measure OD260 and OD280 with the instrument, the RNA concentration is OD260 value × dilution factor × 40 / 1000, calculate...
Embodiment 2
[0094] Example 2 Large sample verification screened out differentially expressed genes
[0095] Considering the gene that has not been studied in the prior art on the correlation between this gene and multiple myeloma as a candidate gene, and considering the results of gene sequencing, the ERI3 gene (its expression is upregulated in multiple myeloma tissues) was selected for verification .
[0096] 1. Sample collection
[0097] According to the method of Example 1, 50 cases of multiple myeloma tissues and 60 cases of normal bone marrow tissues were collected.
[0098] 2. Validation at the mRNA level
[0099] 2.1 Extract tissue RNA
[0100] Step is with embodiment 1.
[0101] 2.2 Reverse transcription
[0102] A total of 20 μL of reverse transcription system, including 2 μg / 2 μL of total cell RNA, 1 μL of 50 U / μL Rnasin, 4 μL of 5× reverse transcription reaction buffer, 2 μl of 10 mM d NTP, 2 μL of 50 μg / mL random primer (promega), 200 U / μL M-MLV Reverse transcriptase 1 μ...
Embodiment 3
[0125] Embodiment 3 suppresses ERI3 gene expression
[0126] 1. siRNA design and synthesis
[0127] siRNA sequences against ERI3:
[0128] siRNA-ERI3:
[0129] The sense strand is 5'-UCUAGAAGUCCAUUCUUGGGC-3' (SEQ ID NO.5)
[0130] The antisense strand is 5'-CCAAGAAUGGACUUCUAGACA-3' (SEQ ID NO.6);
[0131] The above siRNA sequences and negative control siRNA sequences (siRNA-NC) were provided by Shanghai Gemma Pharmaceutical Technology Co., Ltd.
[0132] 2. Culture and transfection of multiple myeloma cells
[0133] 2.1 Cell culture
[0134] RPMI8226 cells were placed in RPMI 1640 medium containing 15% fetal bovine serum (FBS), 100 U / ml penicillin, and 100 μg / ml streptomycin at 37°C, 5% CO 2 , cultivated in a saturated humidity environment.
[0135] 2.2 Cell transfection
[0136] (1) 24 hours before transfection, inoculate 0.5-2*10 5 cells, the cell confluency was 30-50% at the time of transfection. When plating, the cells should be digested and mixed completely to av...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com